實(shí)驗(yàn)方法>
細(xì)胞技術(shù)>
前沿科技及其它>c-myb Antisense Oligonucleotide Therapeutics for Hematologic Malignancies
c-myb Antisense Oligonucleotide Therapeutics for Hematologic Malignancies
關(guān)鍵詞: myb antisense來(lái)源: 互聯(lián)網(wǎng)
Although improved significantly, conventional treatment of hematologic malignancy remains inadequate for many patients. Novel treatment approaches could be useful if they would be more efficacious and less toxic. One such approach could involve the manipulation of genes critical for leukemic cell growth and survival.
推薦方法
- c-erbB-2 Immunohistochemistry in Paraffin Tumors
- Molecular Detection of Smad2/Smad4 Alterations in Colorectal Tumors
- Ex Vivo Assays to Study Self-Renewal and Long-Term Expansion of Genetically Modified Primary Human Acute Myeloid Leukemia Stem C
- Mesoporous Silicon Particles for Sustained Gene Silencing
- Multifactorial Etiology of Gastric Cancer
- In Vitro and In Vivo Apoptosis Detection Using Membrane Permeant Fluorescent-Labeled Inhibitors of Caspases
- Comparative Genomic Hybridization and Fluorescence In Situ Hybridization in Chronic Lymphocytic Leukemia
- Manipulating Expression of Endogenous Oncogenic Proteins Using an Antisense Oligonucleotide Approach in Prostate Cancer Cells
- Statistical Design and Evaluation of Biomarker Studies
- 同一種細(xì)胞,不同質(zhì)粒轉(zhuǎn)染,那G418篩選濃度都一樣嗎